C26H23FIN5O4
615.4 g/mol
APIDanger
Trametinib
CAS871700-17-3
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Trametinib is an active pharmaceutical ingredient that functions as a MEK inhibitor. It is primarily used in the manufacturing of anticancer medications for conditions such as melanoma and glioma.
pharmaceutical raw material for MEK inhibitor drugscomponent in anticancer medication manufacturingresearch compound for oncology studies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 871700-17-3
Related Compounds
ReferenceSame Category
(R)-etodolac
CAS87226-41-3
pharmaceutical raw material
ReferenceSame Category
Emedastine difumarate
CAS87233-62-3
pharmaceutical raw material
ReferenceSame Category
Cefpodoxime proxetil
CAS87239-81-4
pharmaceutical raw material
ReferenceSame Category
(S)-etodolac
CAS87249-11-4
pharmaceutical raw material
Safety Reference
Danger
H317May cause an allergic skin reaction
H361Suspected of damaging fertility or the unborn child
H372Causes damage to organs through prolonged or repeated exposure
H373May cause damage to organs through prolonged or repeated exposure
Identifiers
IUPAC Name
N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide
InChIKey
LIRYPHYGHXZJBZ-UHFFFAOYSA-N
SMILES
CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5
Synonyms (19)
- QOM
- Trametinib (USAN)
- GSK1120212 (Trametinib)
- GSK1120212,JTP-74057, GSK212
- MEK Inhibitor GSK1120212
- Mekinist
- Trametinib
- Trametinib (GSK1120212)
- Trametinib (Standard)
- trametinibum